BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 9595771)

  • 1. [Aflatoxins: current concepts on mechanisms of toxicity and their involvement in the etiology of hepatocellular carcinoma].
    de Oliveira CA; Germano PM
    Rev Saude Publica; 1997 Aug; 31(4):417-24. PubMed ID: 9595771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aflatoxins as a cause of hepatocellular carcinoma.
    Kew MC
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):305-10. PubMed ID: 24078988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular interactions and metabolism of aflatoxin: an update.
    McLean M; Dutton MF
    Pharmacol Ther; 1995 Feb; 65(2):163-92. PubMed ID: 7540767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods.
    Rushing BR; Selim MI
    Food Chem Toxicol; 2019 Feb; 124():81-100. PubMed ID: 30468841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetic alterations caused by aflatoxin b1: a public health risk in the induction of hepatocellular carcinoma.
    Ferreira RG; Cardoso MV; de Souza Furtado KM; Espíndola KMM; Amorim RP; Monteiro MC
    Transl Res; 2019 Feb; 204():51-71. PubMed ID: 30304666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative carcinogenesis and dosimetry in rainbow trout for aflatoxin B1 and aflatoxicol, two aflatoxins that form the same DNA adduct.
    Bailey GS; Loveland PM; Pereira C; Pierce D; Hendricks JD; Groopman JD
    Mutat Res; 1994 Aug; 313(1):25-38. PubMed ID: 7519308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Aflatoxins--health risk factors].
    Miliţă NM; Mihăescu G; Chifiriuc C
    Bacteriol Virusol Parazitol Epidemiol; 2010; 55(1):19-24. PubMed ID: 21038701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aflatoxins as a risk factor for hepatocellular carcinoma in Egypt, Mansoura Gastroenterology Center study.
    Abdel-Wahab M; Mostafa M; Sabry M; el-Farrash M; Yousef T
    Hepatogastroenterology; 2008; 55(86-87):1754-9. PubMed ID: 19102385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage checkpoint response to aflatoxin B1.
    Engin AB; Engin A
    Environ Toxicol Pharmacol; 2019 Jan; 65():90-96. PubMed ID: 30594067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma: from gene to public health.
    Montesano R; Hainaut P; Wild CP
    J Natl Cancer Inst; 1997 Dec; 89(24):1844-51. PubMed ID: 9414172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.
    Wogan GN; Kensler TW; Groopman JD
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2012; 29(2):249-57. PubMed ID: 21623489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism and toxicity of aflatoxins M1 and B1 in human-derived in vitro systems.
    Neal GE; Eaton DL; Judah DJ; Verma A
    Toxicol Appl Pharmacol; 1998 Jul; 151(1):152-8. PubMed ID: 9705898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1.
    McGlynn KA; Rosvold EA; Lustbader ED; Hu Y; Clapper ML; Zhou T; Wild CP; Xia XL; Baffoe-Bonnie A; Ofori-Adjei D
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2384-7. PubMed ID: 7892276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aflatoxin B1: metabolism, toxicology, and its involvement in oxidative stress and cancer development.
    Cao W; Yu P; Yang K; Cao D
    Toxicol Mech Methods; 2022 Jul; 32(6):395-419. PubMed ID: 34930097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin B1 induces persistent epigenomic effects in primary human hepatocytes associated with hepatocellular carcinoma.
    Rieswijk L; Claessen SM; Bekers O; van Herwijnen M; Theunissen DH; Jennen DG; de Kok TM; Kleinjans JC; van Breda SG
    Toxicology; 2016 Mar; 350-352():31-9. PubMed ID: 27153756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan.
    Yu MW; Lien JP; Chiu YH; Santella RM; Liaw YF; Chen CJ
    J Hepatol; 1997 Aug; 27(2):320-30. PubMed ID: 9288607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergism in actions of HBV with aflatoxin in cancer development.
    Jin J; Kouznetsova VL; Kesari S; Tsigelny IF
    Toxicology; 2023 Nov; 499():153652. PubMed ID: 37858775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA damage by mycotoxins.
    Wang JS; Groopman JD
    Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intercalation inhibitor altering the target selectivity of DNA damaging agents: synthesis of site-specific aflatoxin B1 adducts in a p53 mutational hotspot.
    Kobertz WR; Wang D; Wogan GN; Essigmann JM
    Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9579-84. PubMed ID: 9275165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico.
    Soini Y; Chia SC; Bennett WP; Groopman JD; Wang JS; DeBenedetti VM; Cawley H; Welsh JA; Hansen C; Bergasa NV; Jones EA; DiBisceglie AM; Trivers GE; Sandoval CA; Calderon IE; Munoz Espinosa LE; Harris CC
    Carcinogenesis; 1996 May; 17(5):1007-12. PubMed ID: 8640905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.